Achieve Life Sciences Inc at LD Micro Invitational Conference Transcript
Good morning, everyone. I hope you all had a great evening last night or well rested. I'm excited to introduce to you our first presentation of the day, from Achieve Life Sciences, please welcome to the stage, John Bencich.
Morning, everyone. Before we get going, just want to remind everyone I may be making forward-looking statements as part of this presentation, so I encourage everyone to take a look at our filings on SEC.gov and the risk factors contained therein.
At Achieve Life Science, we're focused on the development and ultimately, commercialization of a drug called cytisinicline as an aid to smoking cessation and treatment for nicotine addiction. This is a bit of a unique molecule. This is a product that's been on the market in Europe for 20 years plus, over which time it has treated over 20 million patients.
But it's also a product that's never been brought to the US or any major markets, and that was the opportunity that we identified several years back. Which was to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investorsā 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
